Project Kardium
Kardium Inc. has developed the Globe Pulsed Field System, an integrated cardiac mapping and ablation platform. The system will enable physicians to deliver precise, patient-specific therapy using a 122-electrode spherical array, real-time visualization and tailored electrode selection. The project is a commercial scale-up to expand production of the system from 2,500 devices in the first year to more than 250,000 devices annually within five years.
Province or territory: UNKNOWN · Source-described stage: FDA approval for commercial sale in the US · Source location: Canada — location not yet normalized
What the public record says
Kardium Inc. has developed the Globe Pulsed Field System, an integrated cardiac mapping and ablation platform. The system will enable physicians to deliver precise, patient-specific therapy using a 122-electrode spherical array, real-time visualization and tailored electrode selection. The project is a commercial scale-up to expand production of the system from 2,500 devices in the first year to more than 250,000 devices annually within five years. Source-described stage: FDA approval for commercial sale in the US. Location: Canada — location not yet normalized.
How BuildAtlas reads this record
This record is retained because it helps connect a named project to the capabilities, dependencies, and constraints around delivery.
What to keep in view
What this page does not establish
A source-described stage, capital figure, or proposed capability is not the same as completed construction, committed financing, operating output, or guaranteed delivery. BuildAtlas keeps those distinctions visible.
Read the source record
Primary project evidence is retained with the record and remains attributable to the source. Canada Investment Summit Prospectus · source material observed by BuildAtlas 2026-09-14.
BuildAtlas separates public-source facts, reported statements, and its own clearly labelled interpretation. See the methodology for how to read the evidence.